<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04184583</url>
  </required_header>
  <id_info>
    <org_study_id>ANZHEN HOSPITOL-LY-02</org_study_id>
    <nct_id>NCT04184583</nct_id>
  </id_info>
  <brief_title>Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome</brief_title>
  <official_title>Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Anzhen Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2019</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>6 Years</target_duration>
  <primary_outcome>
    <measure>main adverse cardiovascular and cerebrovascular events (MACCE)</measure>
    <time_frame>up to 5 years</time_frame>
    <description>MACCE will be defined as all-cause death, non-fatal stroke, non-fatal myocardial infarction (MI), and ischemic-driven revascularization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse drug reaction</measure>
    <time_frame>up to 5 years</time_frame>
    <description>Adverse drug reaction will be defined as any adverse reactions in the patients.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Drug Therapy</condition>
  <condition>Acute Coronary Syndrome</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Part of DNA samples were preserved in the -80℃.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Acute Coronary Syndrome with blood concentration monitoring or genetic&#xD;
        testing at the pharmacy department of Beijing Anzhen Hospital from January 1, 2018.Those&#xD;
        who fill the inclusion criteria at screening will be invited for the registry study into&#xD;
        different groups.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Informed consent has been signed.&#xD;
&#xD;
          -  Patients diagnosed in our hospital with acute coronary syndrome.&#xD;
&#xD;
          -  Age ≥18.&#xD;
&#xD;
          -  Life expectancy ≥12 months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe lack of important information such as history of previous medication, history&#xD;
             of previous disease, history of surgery.&#xD;
&#xD;
          -  Pregnant and lactating women.&#xD;
&#xD;
          -  Mental disorders, or inability to communicate effectively with researchers, or failure&#xD;
             to comply with research protocols.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yi Zhang, PhD</last_name>
    <phone>86-010-64456609</phone>
    <email>phd-zhangyi@outlook.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yang Lin, PhD</last_name>
    <phone>86-010-64456609</phone>
    <email>linyang3623@outlook.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Yang Lin, PhD</last_name>
      <phone>86-010-64456609</phone>
      <email>linyang3623@outlook.com</email>
    </contact>
    <contact_backup>
      <last_name>Xiujing Shi, MD</last_name>
      <phone>86-010-64456609</phone>
      <email>xiujingshi@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 28, 2019</study_first_submitted>
  <study_first_submitted_qc>November 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2019</study_first_posted>
  <last_update_submitted>November 29, 2019</last_update_submitted>
  <last_update_submitted_qc>November 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Anzhen Hospital</investigator_affiliation>
    <investigator_full_name>Lin Yang</investigator_full_name>
    <investigator_title>Director of pharmacy department of Beijing Anzhen Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

